iCare DRSplus NHS Diabetic Eye Screening Approval

Mainline Instruments is pleased to announce that the iCare DRSPlus Confocal Fundus Imaging System has been officially approved by the NHS for use in Diabetic Eye Screening (DES). Following a comprehensive assessment process, the D.E.S Programme has confirmed that the iCare DRSPlus meets rigorous clinical standards, validating its suitability for use in both public and private healthcare settings. The iCare DRSPlus has successfully passed the strict criteria outlined by the Diabetic Eye Screening Programme, which ensures that only the highest quality and most reliable diagnostic tools are incorporated into clinical practice. With this approval, the iCare DRSPlus joins a select group of devices now authorised for use in the NHS Diabetic Eye Screening Programme. The iCare DRSPlus is a state-of-the-art retinal imaging system that leverages confocal technology, setting a new benchmark for retinal imaging. By using white LED illumination combined with confocal scanning, the device produces TrueColor, high-definition images that offer unparalleled detail and clarity. Compared to traditional fundus cameras, the DRSPlus provides superior image sharpness, optical resolution, and contrast. DRSPlus Key features:

• High Quality, 45° retinal images through cataracts, aiding clinicians in diagnosing a wide range of ocular diseases, even in patients with media opacities, ensuring that high-quality images are captured with ease.
• Fast, fully automated operation which requires minimal staff training to produce the highest quality images, reducing examination time and improving workflow.
• Confocal Technology allows imaging through pupils as small 2.5mm without the need for dilation, ensuring less disruption and a comfortable experience for the patient.
• Automatic panoramic retinal views up to 80° using the integrated Mosaic function with no user intervention required.
• Optional remote viewer, enabling image review across any workstation within a local network for efficient diagnostics and workflow.

With the iCare DRSPlus, Mainline Instruments continues to provide an advanced, efficient, and accessible screening solution for eye diseases such as diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma. The system’s high-quality images meet the requirements of artificial intelligence (AI) technology on the first take, contributing to faster, more accurate screenings. https://www.main-line.co.uk/wp-content/uploads/DRS-1.pngDISCOVER MORE ABOUT THE iCare DRSplus “We’re delighted that the iCare DRSPlus has received NHS approval for use in the Diabetic Eye Screening Programme,” said Jack Hawkins, Managing Director of Mainline Instruments. “This milestone reflects our ongoing commitment to bringing innovative, clinically proven solutions to eye care professionals. The DRSPlus combines advanced imaging technology with ease of use, helping clinicians deliver faster, more accurate diagnoses and ultimately improving patient outcomes across the UK.” This NHS endorsement underscores Mainline Instruments’ commitment to delivering cutting-edge, patient-focused solutions that advance the quality of care in ophthalmic diagnostics. About Mainline Instruments Mainline Instruments is a leading provider of medical imaging and diagnostic equipment, specialising in innovative solutions for eye care and healthcare settings. With a commitment to quality and cutting-edge technology, Mainline Instruments is dedicated to improving patient care through advanced medical imaging tools. For more information, please contact: Mainline Instruments +44 (0)121 458 6800 [email protected] www.main-line.co.uk